Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy

Added 53 days ago (01.08.2021)
Authors: Anderson, K. G., Oda, S. K., Bates, B. M., Burnett, M. G., Rodgers Suarez, M., Ruskin, S. L., Greenberg, P. D.
Source: bioRxiv
Read article